These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8756739)

  • 81. Autoantibodies to plasminogen and their role in tumor diseases.
    Goufman EI; Yakovlev VN; Tikhonova NB; Aisina RB; Yarygin KN; Mukhametova LI; Gershkovich KB; Gulin DA
    Bull Exp Biol Med; 2015 Feb; 158(4):493-6. PubMed ID: 25708333
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Increased Blood Concentration of IgG Degradation Products in Prostate Cancer.
    Goufman IE; Yakovlev VN; Tikhonova NB; Matevosyan KS; Boltovskaya MN; Aisina RB; Mukhametova LI; Gershkovich KB
    Bull Exp Biol Med; 2019 Mar; 166(5):651-655. PubMed ID: 30903509
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Plasma levels of soluble fibroblast activation protein in arterial thrombosis: determinants and cleavage of its substrate alpha-2-antiplasmin.
    Uitte de Willige S; Malfliet JJ; Deckers JW; Dippel DW; Leebeek FW; Rijken DC
    Int J Cardiol; 2015 Jan; 178():105-10. PubMed ID: 25464232
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Studies on fibrinolytic enzymes in the prostatic gland. II. Activator in the prostatic tissue].
    Chabata T
    Hinyokika Kiyo; 1965 Oct; 11(10):960-72. PubMed ID: 5893282
    [No Abstract]   [Full Text] [Related]  

  • 85. Separation and study of the range of plasminogen isoforms in patients with prostate cancer.
    Shin EF; Vodolazhsky DI; Golikov AY; Belova TN; Boyko NV; Zimakov DV; Cherkasova EN; Kogan MI; Chibichian MB; Moshkovskii SA; Tarasov VA; Matishov DG
    Biochemistry (Mosc); 2012 Sep; 77(9):1065-71. PubMed ID: 23157267
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin: a rebuttal.
    Agustí-Cobos E; Tenorio-Laranga J
    J Thromb Haemost; 2011 Jun; 9(6):1266-7; author reply 1268-9. PubMed ID: 21489129
    [No Abstract]   [Full Text] [Related]  

  • 87. Assay of plasminogen (Plg) and alpha 2-antiplasmin (APL) in septic patients.
    Kordich L; Porterie P; Barazzutti L; Nakkache M; Korin J; Sánchez Avalos JC
    Thromb Res; 1986 Dec; 44(6):899-900. PubMed ID: 2432680
    [No Abstract]   [Full Text] [Related]  

  • 88. Demonstration of two forms of alpha 2-antiplasmin in plasma by modified crossed immunoelectrophoresis.
    Kluft C; Los N
    Thromb Res; 1981 Jan 1-15; 21(1-2):65-71. PubMed ID: 7233403
    [No Abstract]   [Full Text] [Related]  

  • 89. α2 Antiplasmin and microvascular thrombosis in ischemic stroke.
    Su EJ; Lawrence DA
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2522-3. PubMed ID: 25411105
    [No Abstract]   [Full Text] [Related]  

  • 90. Alpha 2-antiplasmin in stroke.
    Albertinale G; Casale G
    Haematologica; 1982; 67(6):946. PubMed ID: 6819204
    [No Abstract]   [Full Text] [Related]  

  • 91. [Studies on fibrinolytic enzymes in the prostatic gland. I. Fibrinolytic activity of fluid of male accessory sexual gland].
    Chabata T
    Hinyokika Kiyo; 1965 Oct; 11(10):945-59. PubMed ID: 5893281
    [No Abstract]   [Full Text] [Related]  

  • 92. [Importance of the paraproteins present in prostatic carcinoma].
    Frea B; Carone R; Tizzani A; Ricci C; Borgno M
    Minerva Urol; 1976; 28(3):112-22. PubMed ID: 1018704
    [No Abstract]   [Full Text] [Related]  

  • 93. FIBRINOLYSIS AND CARCINOMA OF THE PROSTATE.
    SWAN HT; KERRIDGE DF
    J Clin Pathol; 1965 May; 18(3):330-3. PubMed ID: 14304247
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Specific isoforms of plasminogen in patients with prostate cancer.
    Vodolazhsky DI; Shin EF; Golikov AY; Belova TN; Zimakov DV; Cherkasova EN; Boyko NV; Kogan MI; Chibichian MB; Moshkovsky SA; Matishov DG
    Dokl Biol Sci; 2011; 438():141-4. PubMed ID: 21728122
    [No Abstract]   [Full Text] [Related]  

  • 95. Decreased alpha 2-antiplasmin levels in patients suffering from obstructive peripheral arterial disease.
    Frisch EP
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):701-3. PubMed ID: 7444869
    [No Abstract]   [Full Text] [Related]  

  • 96. Revised reference curve for the alpha 2-antiplasmin assay by the addition of detergents.
    Kluft C; Wijngaards G; van Voorthuizen H
    Thromb Haemost; 1984 Apr; 51(2):297. PubMed ID: 6740561
    [No Abstract]   [Full Text] [Related]  

  • 97. [Changes in alpha 2-antiplasmin as a function of meteorological conditions].
    Marongiu F; Mamusa AM; Contu L
    Presse Med; 1984 Apr; 13(17):1099. PubMed ID: 6232542
    [No Abstract]   [Full Text] [Related]  

  • 98. [Changes of plasmatic plasminogen with age].
    Torsellini A; Lombardi V; Niccolai J
    G Gerontol; 1968 Jun; 16(6):575-9. PubMed ID: 5701766
    [No Abstract]   [Full Text] [Related]  

  • 99. [The fibrinolytic enzyme system in the tissue of prostatic tumor].
    KURODA K; HISAZUMI H; KORAI Y
    Nihon Hinyokika Gakkai Zasshi; 1962 Oct; 53():735-53. PubMed ID: 13927522
    [No Abstract]   [Full Text] [Related]  

  • 100. [Levels of plasminogen and alpha 2-antiplasmin in blood of patients with prostatic tumor].
    Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F
    Pol Tyg Lek; 1996 Feb; 51(6-9):86-8. PubMed ID: 8756739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.